Pegvisomant in acromegaly: an update

BACKGROUND: In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety. AIM: We here reviewed the emerging aspects of the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Giustina, A., Arnaldi, G., Bogazzi, F., Cannavò, S., Colao, A., De Marinis, L., De Menis, E., Degli Uberti, E., Giorgino, F., Grottoli, S., Lania, A. G., Maffei, P., Pivonello, R., Ghigo, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443862/
https://www.ncbi.nlm.nih.gov/pubmed/28176221
http://dx.doi.org/10.1007/s40618-017-0614-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443862/
https://www.ncbi.nlm.nih.gov/pubmed/28176221
http://dx.doi.org/10.1007/s40618-017-0614-1

Ejemplares similares